• Login
  • Explore
    • Maps
    • Lists
    • Tags
  • About
    • LittleSis
    • Sign Up
    • Help
    • API
    • Disclaimer
    • Contact Us
    • Donate
    • Newsletter
  • Features
    • Blog
    • Toolkit
    • Powerlines
  • Login
  • Explore
    • Maps
    • Lists
    • Tags
  • About
    • LittleSis
    • Sign Up
    • Help
    • API
    • Disclaimer
    • Contact Us
    • Donate
    • Newsletter
  • Features
    • Blog
    • Toolkit
    • Powerlines
donate

Mark A Prygocki Sr

Mark A. Prygocki, Sr. has served as a director and chairman of the Revance audit committee since May 2014. Mr. Prygocki currently serves on the Board of Directors of Clarus Therapeutics, Inc. as well as Chairman of its audit committee. Mr. Prygocki is a pharmaceutical industry leader with over 20 years of experience, specializing in corporate strategy and operational efficiency. He worked at Medicis Pharmaceutical Corporation for more than 20 years and served as President from July 2010 to December 2012. Prior to that, Mr. Prygocki held several senior‐level positions at Medicis, including Chief Operating Officer, Executive Vice President, and Chief Financial Officer and Treasurer. Mr. Prygocki’s previous experience includes work at Citigroup, an investment banking firm, in the regulatory reporting division. Prior to that, Mr. Prygocki spent several years in the audit department of Ernst & Young, LLP. He holds a B.S. in accounting from Pace Uiversity and is certified by the Arizona State Board of Accountancy and the New York Society of CPAs. Mr. Prygocki serves on the board of Whispering Hope Ranch Foundation, a non-profit organization that assists children with special needs.

Relationships Interlocks Giving Data
People in Common Orgs
People with positions in the same orgs as Mark A Prygocki Sr
PersonCommon Orgs
Phyllis Gardner Revance Therapeutics, Inc.
Angus C Russell Revance Therapeutics, Inc.
Dan Browne Revance Therapeutics, Inc.
Robert Byrnes Revance Therapeutics, Inc.
Ronald Eastman Revance Therapeutics, Inc.
James Glasheen Revance Therapeutics, Inc.
Jonathan Tunnicliffe Revance Therapeutics, Inc.
Philip J Vickers Revance Therapeutics, Inc.
Ronald Wooten Revance Therapeutics, Inc.
Mark A Prygocki Sr
Updated over 10 years ago

Basic Info

Types Person, Business Person

Source Links

9 documents :: see all
  • FEC Filing 28991480738
  • FEC contribution search
  • FEC Filing 20990084724
  • FEC Filing 20036582298
  • FEC Filing 94020223408
  • FEC Filing 98033470422
  • FEC Filing 10020680867
  • FEC Filing 11020292041
  • Revance Board bios - 2015
A project of the Public Accountability Initiative. More about LittleSis. Read the disclaimer.